Filing Details

Accession Number:
0001562180-19-005623
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-21 06:32:47
Reporting Period:
2019-11-20
Accepted Time:
2019-11-21 06:32:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA Pharmaceutical Preparations (2834) 208756903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591467 P. John Butler C/o Akebia Therapeutics, Inc.
245 First Street
Cambridge MA 02142
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-20 50,000 $3.44 887,732 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 59,928 Indirect Held by Dorothy Butler 2019 GRAT
Common Stock 31,047 Indirect Held by Dorothy Butler Revocable Trust 2007
Common Stock 59,928 Indirect Held by John Butler 2019 GRAT
Common Stock 31,047 Indirect Held by John Butler Revocable Trust 2007
Footnotes
  1. The purchase reported in this Form 4 was made on the open market.
  2. The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.22 to $3.65, inclusive. The reporting person undertakes to provide Issuer, any security holder of Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
  3. Includes 1,500 shares of the Issuer's common stock purchased under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan on June 28, 2019.